ClinicalTrials.gg
CompletedNCT07875621Updated Oct 19, 2026

Self-Leadership Training and Work Performance and Job Autonomy Among Healthcare Workers in Egypt

An interventional study of Self-Leadership Training Program in Self Leadership, Health Care Worker (HCW) and Training Effectiveness, sponsored by Tanta University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Tanta University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Jan 2025, registered Oct 2026).
Updated Oct 15, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study tests whether a structured self-leadership training program can help healthcare workers at a university hospital in Egypt. Self-leadership means the ability to guide your own thoughts and actions toward your goals. Resident physicians and nurses at Tanta University Hospitals first completed a questionnaire that measures self-leadership. Those with low scores who agreed to take part joined an 8-week program of weekly group sessions. Participants answered questionnaires about self-leadership, work performance, and job autonomy (how much control they have over their work) before the program, right after it, and again 3 months later. The study aims to find out whether these scores change after the program and whether any change lasts.

Read the detailed description

Background: Self-leadership is the capacity to direct one's own thoughts and behavior toward goals. It may help healthcare workers maintain performance under high job demands. Evidence from interventional studies in low- and middle-income countries is limited.

Design: Single-arm, pre-post intervention study (a quasi-experimental design without a concurrent control group) with a 3-month follow-up, conducted at Tanta University Hospitals, Egypt, from January to July 2025. The study was registered retrospectively, after enrolment had begun. It is reported in accordance with the TREND guideline for non-randomized evaluations.

Participants: Resident physicians and nurses were screened with the Revised Self-Leadership Questionnaire (RSLQ; score range 35 to 175). Those who scored 58 or less and gave informed consent were enrolled.

Intervention: An 8-week self-leadership training program, delivered in weekly 2-hour group sessions (groups of 10 participants) during breaks in working hours, with weekly homework using a participant workbook. Details of the sessions are given in the supplementary material of the associated manuscript.

Assessments: Self-reported questionnaires at baseline (T0), after the program (T1), and at 3 months (T2): RSLQ for self-leadership, the Six-Dimension Scale of Performance for work performance, and the Work Design Questionnaire (autonomy scales) for job autonomy.

Analysis: Changes from T0 to T1 are compared with paired t tests, and changes across T0, T1, and T2 with repeated-measures ANOVA. Factors associated with change in self-leadership are examined with multiple linear regression. Analyses include participants who completed all three assessments.

02

Conditions studied

  • Self Leadership
  • Health Care Worker (HCW)
  • Training Effectiveness

Keywords

  • self leadership
  • health care workers
  • training effectiveness
03

In context

Lead sponsor

Tanta University is the lead sponsor of 991 studies on the registry; 316 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Resident physicians and nursing staff employed at Tanta University Hospitals
  • Score of 58 or less on the Revised Self-Leadership Questionnaire (RSLQ; low self-leadership category)
  • Willing to attend the 8-week program
  • Able to complete all assessments
  • Informed consent to participate

Exclusion criteria

Exclusion Criteria:

  • Extended leave during the intervention period
  • Previous formal self-leadership training
  • Mental health condition that would interfere with participation
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
180 participants (actual)

Study arms

  • Experimental
    Self-Leadership Training

    Behavioral: Self-Leadership Training Program

Interventions

  • BehavioralSelf-Leadership Training Program

    An 8-week structured self-leadership training program delivered in weekly 2-hour group sessions (groups of 10 participants) during breaks between working hours. Participants completed weekly homework using a participant workbook.

06

What researchers measure

Primary outcomes

  1. Change in self-leadership score

    Self-leadership measured with the Revised Self-Leadership Questionnaire (RSLQ), 35 items, total score range 35 to 175. Higher scores indicate higher self-leadership. Change is assessed from baseline (T0) to immediately after the program (T1) and to 3 months after the program (T2).

    Time frame: Baseline, immediately after the 8-week program, and 3 months after the program

Secondary outcomes

  1. Change in Work Performance Score on the Six-Dimension Scale of Performance

    Work performance was self-reported using the Six-Dimension Scale of Performance. Scores range from \[minimum\] to \[maximum\]. Higher scores indicate better work performance (a better outcome).

    Time frame: Baseline, immediately after the 8-week program, and 3 months after the program

  2. Change in Job Autonomy Score on the Work Design Questionnaire Autonomy Scales

    Job autonomy was measured with the three autonomy scales of the Work Design Questionnaire: work scheduling autonomy, decision-making autonomy, and work methods autonomy. Each item is rated from \[1 (strongly disagree)\] to \[5 (strongly agree)\]. Scores range from \[minimum\] to \[maximum\] for \[each subscale / the combined autonomy score\]. Higher scores indicate greater job autonomy (a better outcome).

    Time frame: Baseline, immediately after the 8-week program, and 3 months after the program

07

Study locations

1 site
  • Tanta University
    Tanta, 13719, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

Time frame: Data will be available upon publication of the associated article.

Access criteria: Requests should be sent to the corresponding author by email. Data will be shared for academic research purposes after review of the request.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2025 to primary completion in Jul 2025, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2026
First posted
Oct 15, 2026
StartActual
Jan 1, 2025
Primary completionActual
Jul 1, 2025
CompletionActual
Dec 1, 2025
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 2 updates
  1. Oct 19, 2026
    Minor edits only
    + 2 other changes: conditions and secondary outcomes
  2. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07875621
Lead sponsor
Tanta University
Responsible party
abdelrhman ali elghorab (Assistant Lecturer of Neuropsychiatry, Tanta University) — Principal investigator
First posted
Oct 15, 2026
Start date
Jan 1, 2025
Primary completion
Jul 1, 2025
Completion
Dec 1, 2025
Last update
Oct 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion